Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy | Zendy

Nicholas D. James | Zendy; Johann S. de Bono | Zendy; Melissa Spears | Zendy; Noel W. Clarke | Zendy; Malcolm D. Mason | Zendy; David P. Dearnaley | Zendy; A.W.S. Ritchie | Zendy; Claire Amos | Zendy; Clare Gilson | Zendy; Robert J. Jones | Zendy; David Matheson | Zendy; Robin Millman | Zendy; Gerhardt Attard | Zendy; Simon Chowdhury | Zendy; William Cross | Zendy; Silke Gillessen | Zendy; Christopher Parker | Zendy; John M. Russell | Zendy; Dominik Berthold | Zendy; Christopher D. Brawley | Zendy; F. Adab | Zendy; San Aung | Zendy; Alison Birtle | Zendy; Jo Bowen | Zendy; Susannah Brock | Zendy; Prabir Chakraborti | Zendy; Catherine Ferguson | Zendy; Joanna Gale | Zendy; Emma Gray | Zendy; Mohan Hingorani | Zendy; Peter Hoskin | Zendy; J.F. Lester | Zendy; Zafar Malik | Zendy; Fiona McKinna | Zendy; Neil McPhail | Zendy; Julian MoneyKyrle | Zendy; Joe M. O’Sullivan | Zendy; Omi Parikh | Zendy; Andrew Protheroe | Zendy; Angus Robinson | Zendy; Narayanan Srihari | Zendy; Carys Thomas | Zendy; John Wagstaff | Zendy; James Wylie | Zendy; Anjali Zarkar | Zendy; Mahesh Parmar | Zendy; Matthew R. Sydes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Author(s) -

Nicholas D. James,

Johann S. de Bono,

Melissa Spears,

Noel W. Clarke,

Malcolm D. Mason,

David P. Dearnaley,

A.W.S. Ritchie,

Claire Amos,

Clare Gilson,

Robert J. Jones,

David Matheson,

Robin Millman,

Gerhardt Attard,

Simon Chowdhury,

William Cross,

Silke Gillessen,

Christopher Parker,

John M. Russell,

Dominik Berthold,

Christopher D. Brawley,

F. Adab,

San Aung,

Alison Birtle,

Jo Bowen,

Susannah Brock,

Prabir Chakraborti,

Catherine Ferguson,

Joanna Gale,

Emma Gray,

Mohan Hingorani,

Peter Hoskin,

J.F. Lester,

Zafar Malik,

Fiona McKinna,

Neil McPhail,

Julian MoneyKyrle,

Joe M. O’Sullivan,

Omi Parikh,

Andrew Protheroe,

Angus Robinson,

Narayanan Srihari,

Carys Thomas,

John Wagstaff,

James Wylie,

Anjali Zarkar,

Mahesh Parmar,

Matthew R. Sydes

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1702900

Subject(s) - abiraterone acetate , prostate cancer , abiraterone , androgen deprivation therapy , medicine , oncology , testosterone (patch) , cancer , prostate , hormone therapy , prednisolone , urology , androgen receptor , breast cancer

Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial design.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research